Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 450 | nsp3:A450T; | CL-3b; |
| 465 | nsp3:A465-; | CL-2;CL-3d;CL-3e;CL-3f; |
| 480 | nsp3:A480-; | CL-1a_3b;CL-1a_3c;CL-3b;CL-3e;CL-3f; |
| 488 | nsp3:A488-; | CL-3e; |
| 488 | nsp3:A488S; | CL-3e; |
| 488 | nsp3:A488T; | CL-1a;CL-3b;CL-3d;CL-3e; |
| 488 | nsp3:A488V; | CL-3c;CL-3d;CL-3f; |
| 496 | nsp3:A496T; | CL-3e; |
| 498 | nsp3:A498-; | CL-3e; |
| 498 | nsp3:A498S; | CL-3b; |
| 498 | nsp3:A498T; | CL-3e; |
| 524 | nsp3:A524-; | CL-3e; |
| 524 | nsp3:A524V; | CL-3d; |
| 534 | nsp3:A534-; | CL-3b;CL-3c;CL-3e; |
| 534 | nsp3:A534D; | CL-1a; |
| 562 | nsp3:A562-; | CL-1a_3e;CL-3b; |
| 562 | nsp3:A562E; | CL-3d; |
| 562 | nsp3:A562G; | CL-3d; |
| 562 | nsp3:A562T; | CL-3b;CL-3c; |
| 564 | nsp3:A564-; | CL-1b;CL-3e; |
| 564 | nsp3:A564S; | CL-3e; |
| 58 | nsp3:A58-; | CL-1a;CL-3c;CL-5; |
| 58 | nsp3:A58S; | CL-3b;CL-5; |
| 602 | nsp3:A602-; | CL-3b; |
| 602 | nsp3:A602S; | CL-3c; |
| 602 | nsp3:A602T; | CL-3c; |
| 60 | nsp3:A60S; | CL-3e; |
| 614 | nsp3:A614-; | CL-3f; |
| 614 | nsp3:A614S; | CL-3a;CL-3b;CL-3e; |
| 614 | nsp3:A614T; | CL-3e;CL-3f; |
| 644 | nsp3:A644S; | CL-3b;CL-3e; |
| 644 | nsp3:A644T; | CL-3f; |
| 655 | nsp3:A655-; | CL-3b;CL-3e;CL-3f; |
| 655 | nsp3:A655T; | CL-3c;CL-3d; |
| 664 | nsp3:A664-; | CL-3d; |
| 664 | nsp3:A664V; | CL-3c;CL-3d;CL-3e;CL-3f; |
| 667 | nsp3:A667V; | CL-3b;CL-3d;CL-3e; |
| 690 | nsp3:A690-; | CL-3e; |
| 690 | nsp3:A690V; | CL-1b;CL-3b;CL-3e; |
| 784 | nsp3:A784-; | CL-3b;CL-3d; |
| 784 | nsp3:A784S; | CL-2; |
| 813 | nsp3:A813-; | CL-3b;CL-3e; |
| 831 | nsp3:A831S; | CL-3b;CL-3e; |
| 831 | nsp3:A831T; | CL-3b;CL-3e; |
| 859 | nsp3:A859-; | CL-3b;CL-3c;CL-3e; |
| 861 | nsp3:A861-; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 876 | nsp3:A876-; | CL-3b;CL-3e; |
| 876 | nsp3:A876V; | CL-3e; |
| 880 | nsp3:A880-; | CL-1b;CL-3e; |
| 880 | nsp3:A880S; | CL-1b; |
Page 253 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com